Research Tax Credit [Abstract] Research Tax Credit Disclosure [Text Block] Research Tax Credit Disclosure [Text Block] The entire disclosure related to research tax credit. Stockholders' Equity Note [Abstract] Stockholders Equity Note Disclosure [Text Block] Stockholders' Equity Note Disclosure [Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Abstract] Disclosure Of Compensation Related Costs, Share-Based Payments [Text Block] Disclosure of Compensation Related Costs, Share-based Payments [Text Block] Debt Disclosure [Abstract] Long-term Debt [Text Block] Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Subsequent Events [Abstract] Subsequent Events [Text Block] Schedule Of Earnings Per Share Basic and Diluted Before Stock Based Compensation [Table Text Block] Schedule Of Earnings Per Share Basic and Diluted Before Stock Based Compensation [Table Text Block] Tabular disclosure of an entity's basic and diluted earnings per share calculations before the stock based compensation. Schedule of Long-term Debt Instruments [Table Text Block] Schedule Of Fair Value Assumptions Of Warrant [Table Text Block] Tabular disclosure for fair value assumptions of warrants. Schedule of Maturities of Long-term Debt [Table Text Block] Schedule of Fair Value, Assets and Liabilities Measured on Recurring Basis [Table Text Block] Schedule Of Remeasurement Of Acquired Liabilities [Table Text Block] Tabular disclosure for remeasurement of acquired liabilities. License, Research and Consulting Agreements [Abstract] Statement [Table] Statement [Table] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition, Acquiree [Domain] Business Acquisition, Acquiree [Domain] Eclat Pharmaceuticals [Member] Merck Serono [Member] Undisclosed Partners [Member] Gsk [Member] Products and Services [Axis] Products and Services [Axis] License and Research Revenue License and research revenue Revenue earned during the period relating to licensing fees and research revenue. Research Revenues Research Revenues Revenue earned during the period relating to research revenue. Licenses Revenue Licenses Revenue Sales Revenue Goods and Services Net Product sales and services Aggregate revenue during the period from the sale of goods in the normal course of business and also from providing service for the goods. Other Revenue, Net Other revenues Income Statement [Abstract] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Statement [Line Items] Statement [Line Items] Statement [Line Items] Revenues [Abstract] Revenue: Revenue, Net, Total Total revenue Costs and Expenses [Abstract] Costs and expenses: Cost of Goods and Services Sold, Total Cost of goods and services sold Research and Development Expense, Total Research and development Selling, General and Administrative Expense, Total Selling, general and administrative Fair Value Measurement Of Acquisition Liabilities Fair value remeasurement of acquisition liabilities, incl. related parties Represents the fair value measurement of acquisition liabilities Costs and Expenses, Related Party Acquisition note expenses, incl. related parties Operating Income (Loss), Total Profit (loss) from operations Investment Income, Net, Total Interest income net Interest Expense, Debt Interest expense on debt related to the royalty agreement with related parties Foreign Currency Transaction Gain (Loss), before Tax Foreign exchange gain (loss) Other Nonoperating Income Other income (loss) Income (Loss) from Continuing Operations before Equity Method Investments, Income Taxes, Extraordinary Items, Noncontrolling Interest, Total Income (loss) before income taxes Income Tax Expense (Benefit) Income tax benefit (expense) Net Income (Loss) Attributable to Parent, Total Net income (loss) Net Income (loss) Net income (loss) Net loss Earnings Per Share [Abstract] Earnings (loss) per share Net income (loss) per share Earnings Per Share, Basic, Total Basic earnings (loss) per ordinary share Basic (in dollars per share) Earnings Per Share, Diluted, Total Diluted earnings (loss) per share Diluted (in dollars per share) Weighted Average Number Of Shares Outstanding, Diluted [Abstract] Weighted average number of shares outstanding (in thousands) : Number of shares used for computing (weighted average) Number of shares used for computing Weighted Average Number of Shares Outstanding, Basic, Total Basic (in shares) Weighted Average Number of Shares Outstanding, Diluted Diluted (in shares) Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount Income Tax Reconciliation, Tax Credits, Research Subsidiary, Sale of Stock [Axis] Share-Based Compensation Arrangement By Share-Based Payment Award, Options, Exercises In Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Income Statement Location [Axis] Schedule of Employee Service Share-based Compensation, Allocation of Recognized Period Costs, by Report Line [Axis] Income Statement Location [Domain] Employee Service Share-based Compensation, Allocation of Recognized Period Costs, Report Line [Domain] Cost of Sales [Member] Cost of Products and Services Sold [Member] Research and Development Expense [Member] Research and Development [Member] Selling, General and Administrative Expenses [Member] Selling, General and Administrative [Member] Share-Based Compensation [Abstract] Stock-based compensation (ASC 718) Allocated Share-based Compensation Expense, Total Total Net Income Loss From Operations Before Stock Based Compensation Net income (loss) before stock-based compensation The portion of profit or loss for the period, net of income taxes, which is attributable to the parent but before the stock based compensation. Earnings Per Share Before Stock Based Compensation [Abstract] Net income (loss) before stock-based compensation per share Earnings Per Share Basic Before Stock Based Compensation Basic (in dollars per share) The amount of net income (loss) before the stock based compensation for the period per each share of common stock or unit outstanding during the reporting period. Earnings Per Share Dilutedbefore Stock Based Compensation Diluted (in dollars per share) The amount of net income (loss) before the stock based compensation for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Long-term Debt, Type [Axis] Long-term Debt, Type [Domain] Government Loans For Research And Development Projects [Member] Acquisition Liability Contingent Consideration [Member] Acquisition Liability Note [Member] Acquisition Liability Warrant Consideration [Member] Facility Agreement [Member] Deerfield Facility Agreement [Member] Fair Value, Hierarchy [Axis] Long-term Debt, Total Total Long-term Debt, Current Maturities, Total Current portion Current portion of long-term debt, incl to related parties Long-term Debt, Excluding Current Maturities, Total Long-term portion Long-term debt, less current portion, incl. to related parties Equity Components [Axis] Statement, Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Warrant [Member] Share Price Share price Fair Value Assumptions, Risk Free Interest Rate Risk-free interest rate Fair Value Assumptions, Expected Dividend Rate Dividend yield Fair Value Assumptions, Expected Volatility Rate Expected volatility Fair Value Assumptions, Expected Term Expected term Long-term Debt, Maturities, Repayments of Principal, Remainder of Fiscal Year 2014 Long-term Debt, Maturities, Repayments of Principal in Year Two 2015 Long-term Debt, Maturities, Repayments of Principal in Year Three 2016 Long-term Debt, Maturities, Repayments of Principal in Year Four 2017 Long-term Debt, Maturities, Repayments of Principal in Year Five 2018 Long Term Debt Other Long Term Liabilities Long-term Debt, Total Carrying amount of long-term debt, net of unamortized discount or premium, including current and noncurrent amounts and other long term liabilities. American Depository Shares [Member] Hycet [Member] Percentage Of Earn Out Payment Represents the percentage of earn out payment. Secured Debt Class of Warrant or Right, Number of Securities Called by Warrants or Rights Fair Value Inputs, Discount Rate Debt Financing Facility Agreement Amount Represents the amount of debt financing facility agreement. Fund Raised From Debt Financing Facility Total amount of fund raised from debt financing agreement. Premium On Reimbursement Represents the amount of premium on reimbursement. Long Term Debt Repayment Percentage Represents the percentage of debt repayment. Debt Repayment Term Represents term of debt repayment in CCYY-MM-DD format. Deerfield Royalty Agreement [Member] Investment Type [Axis] Investments [Domain] Cash and Cash Equivalents [Member] Marketable Securities [Member] Fair Value Hierarchy [Domain] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Assets [Abstract] ASSETS Cash and Cash Equivalents, at Carrying Value, Total Cash and cash equivalent Cash and cash equivalents Cash and cash equivalents, beginning of period Cash and cash equivalents, end of period Marketable Securities, Current, Total Marketable securities Marketable securities Liabilities [Abstract] Liabilities LIABILITIES Business Acquisition Contingent Consideration Net Acquisition liability contingent consideration Net fair value, as of the acquisition date, of potential payments under the contingent consideration arrangement including cash and shares. Operational Gain Loss On Fair Value Hedges Recognized In Earnings Operational Gain (losses) recognized in earnings Represents the operational amount of gain (loss) derived from fair value hedges recognized in earnings in the period. Financial Gain Loss On Fair Value Hedges Recognized In Earnings Financial Gain (losses) recognized in earnings Represents the financial amount of gain (loss) derived from fair value hedges recognized in earnings in the period. Gain (Loss) on Fair Value Hedges Recognized in Earnings, Total Total Statement of Comprehensive Income [Abstract] Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent [Abstract] Other comprehensive income (loss): Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Gain (Loss) Arising During Period, Net of Tax Net foreign currency translation gain (loss) Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent, Total Other comprehensive income (loss), net of tax Other comprehensive income (loss) Comprehensive Income (Loss), Net of Tax, Attributable to Parent, Total Comprehensive Income (loss) Fair Value Measurement With Unobservable Inputs Reconciliations Acquired Liability Value Liability recorded upon acquisition Net carrying value This element represents a acquired liability measured at fair value using significant unobservable inputs (Level 3) which is required for reconciliation purposes of beginning and ending balances. Remeasurement Of Acquisition Liabilities And Royalty Agreement Operational gain (loss) recognized in earnings Remeasurement of acquisition liabilities and royalty agreement Represents the remeasurement of acquisition liabilities and Royalty agreement. Payments to Acquire Notes Receivable Payment of interest on acquisition liability note Payment For Reimbursements Reimbursement of acquisition liability note Represents the amount paid for reimbursement. Statement Of Financial Position [Abstract] Accounts Receivable, Net, Current, Total Accounts receivable (net of allowance of $144 and $146 at December 31, 2013, and March 31, 2014 respectively) Inventory, Net, Total Inventory Inventories, net Research and Development Tax Credit Receivable Current Research and development tax credit receivable short term The current portion of tax credit receivable on research and development as on the balance sheet date. Prepaid Expense and Other Assets, Current Prepaid expenses and other current assets Assets, Current, Total Total current assets Assets, Current [Abstract] Current assets Goodwill Goodwill, net Property, Plant and Equipment, Net, Total Property and equipment, net Intangible Assets, Net (Excluding Goodwill), Total Intangible assets Research and Development Tax Credit Receivable Non Current Research and development tax credit receivable long term The non current portion of tax credit receivable on research and development as on the balance sheet date. Other Long-Term Investments Other long-term assets Other Assets [Abstract] Other assets: Capital Lease Obligations, Current Current portion of capital lease obligations Accounts Payable, Current Accounts payable Deferred Revenue, Current Current portion of deferred revenue Customer Advances, Current Advances from customers Accrued Liabilities, Current Accrued expenses Other Liabilities, Current Other current liabilities Liabilities, Current, Total Total current liabilities Liabilities, Current [Abstract] Current liabilities Capital Lease Obligations, Noncurrent Capital lease obligations, less current portion Deferred Tax Liabilities, Net, Noncurrent Deferred tax liabilities Other Liabilities, Noncurrent Other long-term liabilities Liabilities, Noncurrent, Total Total long-term liabilities Common Stock, Value, Issued Ordinary shares: 25,612,550 issued and outstanding at December 31, 2013 and 38,267,550 at March 31, 2014 (shares authorised 46,730,190) at nominal value of 0.122 euro Additional Paid In Capital, Common Stock Additional paid-in capital Retained Earnings (Accumulated Deficit), Total Accumulated deficit Accumulated Other Comprehensive Income (Loss), Net of Tax, Total Accumulated other comprehensive income (loss) Stockholders Equity Attributable to Parent, Total Total shareholders' equity Balance Balance Stockholders Equity Attributable To Parent [Abstract] Shareholders' equity: Balance Sheets Parenthetical [Abstract] Allowance for Doubtful Accounts Receivable, Current Allowance for accounts receivable (in dollars) Common Stock, Par or Stated Value Per Share Common stock, par value (in euro per share) Common Stock, Shares Authorized Common stock, shares authorized Common Stock, Shares, Issued Common stock, shares issued Statement Of Cash Flows [Abstract] Net Cash Provided By (Used In) Operating Activities [Abstract] Cash flows from operating activities: Depreciation, Depletion and Amortization, Total Depreciation of property and equipment Gain (Loss) on Disposition of Property Plant Equipment, Total Loss (gain) on disposal of property, equipment and inventory Grants Recognized In Other Income and Income From Operations Grants recognized in other income and income from operations The amount of grants recognized in other income and income from operations during the reporting period. Share-based Compensation, Total Stock compensation expense Increase (Decrease) in Deferred Income Taxes Income tax Increase (Decrease) In Operating Capital [Abstract] Increase (decrease) in cash from: Increase (Decrease) In Accounts Receivable Accounts receivable Increase (Decrease) in Inventories, Total Inventory Increase (Decrease) in Prepaid Expense and Other Assets, Total Prepaid expenses and other current assets Increase (Decrease) In Research and Development Tax Credit Receivable Research and development tax credit receivable The increase (decrease) during the reporting period in research and development tax credit receivable. Increase (Decrease) in Accounts Payable, Total Accounts payable Increase (Decrease) In Deferred Revenue Deferred revenue Increase (Decrease) in Accrued Liabilities, Total Accrued expenses Increase (Decrease) In Other Current Liabilities Other current liabilities Increase (Decrease) In Other Noncurrent Assets and Liabilities, Net Other long-term assets and liabilities Net Cash Provided by (Used in) Operating Activities, Total Net cash provided by (used in) operating activities Net Cash Provided By (Used In) Investing Activities [Abstract] Cash flows from investing activities: Payments to Acquire Property, Plant, and Equipment, Total Purchases of property and equipment Proceeds from Sale of Property, Plant, and Equipment, Total Proceeds from disposal of property and equipment Payments to Acquire Marketable Securities, Total Purchase of marketable securities Proceeds from Sale of Available-for-sale Securities, Total Proceeds from sales of marketable securities Net Cash Provided by (Used in) Investing Activities, Total Net cash provided by (used in) investing activities Net Cash Provided By (Used In) Financing Activities [Abstract] Cash flows from financing activities: Proceeds from Issuance of Long-term Debt, Total Proceeds from loan or conditional grants Repayments of Long-term Debt, Total Reimbursment of loan Earnout Payments For Acquisition Earnout payments for acquisition including related parties The cash outflow for earnout payments for acquisition. Repayments Of Long-Term Capital Lease Obligations Principal payments on capital lease obligations Proceeds from Issuance or Sale of Equity, Total Cash proceeds from issuance of ordinary shares and warrants Net Cash Provided by (Used in) Financing Activities, Total Net cash provided by (used in) financing activities Effect of Exchange Rate on Cash and Cash Equivalents, Total Effect of exchange rate changes on cash and cash equivalents Cash and Cash Equivalents, Period Increase (Decrease), Total Net increase (decrease) in cash and cash equivalents Supplemental Cash Flow Information [Abstract] Supplemental disclosures of cash flow information: Income Taxes Paid Income tax paid Interest Paid, Total Interest paid Other Noncash Investing and Financing Items [Abstract] The supplemental schedule of non cash investing and financing activities is as follows Statement Of Stockholders Equity [Abstract] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Accumulated Other Comprehensive Income (Loss) [Member] Shares, Outstanding, Beginning Balance Balance (in shares) Balance (in shares) Adjustments to Additional Paid in Capital, Warrant Issued Subscription of warrants Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Value Exercisable Issuance of ordinary shares on exercise of warrants Value of equity instruments other than options exercisable as of the balance sheet date. Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercisable Number Issuance of ordinary shares on exercise of warrants (in shares) Number of equity instruments other than options exercisable as of the balance sheet date. Stock Issued During Period, Value, On Capital Raise Issuance of ordinary shares on Capital raise Value of shares of stock issued during the period as part of a transaction to raise capital. Stock Issued During Period, Shares, On Capital Raise Issuance of ordinary shares on Capital raise (in shares) The Number Of Shares Issued During The Period To Raise Capital Adjustments to Additional Paid in Capital, Share-based Compensation, Requisite Service Period Recognition, Total Stock-based compensation expense Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation Of Financial Statements Disclosure and Significant Accounting Policies [Text Block] Organization, Consolidation and Presentation of Financial Statements Disclosure and Significant Accounting Policies [Text Block] License, Research and Consulting Agreements Disclosure [Text Block] License, Research and Consulting Agreements Disclosure [Text Block] The entire disclosure for the license, research and consulting agreements that were made with the customers during the period. Document And Entity Information [Abstract] Document Information [Table] Broadfin Facility Agreement [Member] Broadfin Royalty Agreement [Member] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Text Block] Schedule of Finite-Lived Intangible Assets [Table Text Block] Sales Revenue, Goods, Net, Total Royalty Agreement [Member] Sales Revenue, Goods, Gross Finite-Lived Intangible Assets [Line Items] Research and Development In Process [] [Member] Research and Development In Process [Member] IPR D of Bloxiverz [Member] IPR&D of Bloxiverz [Menber] Finite-Lived Intangible Assets, Gross Gross carrying amount Finite-Lived Intangible Assets, Accumulated Amortization Accumulated amortization Impairment of Intangible Assets, Finite-lived Impairment Finite-Lived Intangible Assets, Net Intangible assets, net Products and Services [Domain] Bloxiverz [Member] Inventory Disclosure [Abstract] Inventory Disclosure [Text Block] Related Party Transactions [Abstract] Related Party Transactions Disclosure [Text Block] Schedule of Inventory, Current [Table Text Block] Inventory [Line Items] Inventory [LineItems] Inventory, Raw Materials, Gross Raw materials Inventory, Finished Goods, Gross Finished goods Warrants Issued During Period Warrants New Issues Number of new warrants issued during the period. Deferred Revenue Initial Loan Amount Represents the amount of initial loan made. Contingent Potential Cash Payment Amount of potential cash payments that could result from the contingent consideration arrangement. Line of Credit Facility, Maximum Borrowing Capacity Line Of Credit Facility Initial Loan The initial loan amount under the credit facility. Line Of Credit Facility Additional Loan Additional loan amount under the credit facility. Stock Issued During Period, Shares, New Issues Royalty Percentage Percentage of royalty payable on net sales. Shares Issued, Price Per Share Business Combination Commitment Percentage Represents the percentage of gross profit which is a commitment to pay under business combination. Payment of Commission Price Per Share Amount per share or per unit included for the payment of a commission. Stock Issued During Period, Value, New Issues Finite-Lived Intangible Asset, Useful Life Payments for Fees Proceeds from Issuance Initial Public Offering Common Stock, Shares, Outstanding Common stock, shares outstanding Debt Instrument [Axis] Debt Instrument [Axis] Research and Development Arrangement, Contract to Perform for Others, Type [Axis] Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Senior Secured Six Year Note [Member] Amortization of Intangible Assets Amortisation of intangible R&D assets Costs and Expenses, Total Total Research and Development Arrangement, Contract to Perform for Others, Type [Domain] Operating Expenses, Total Interest Expense, Total Calculated Interest on amortized method Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Inputs Reconciliation, Gain (Loss) Included in Earnings Interest expense recognized in earnings for 2013 Sale of Stock, Name of Transaction [Domain] IPO [Member] Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Entity Filer Category Trading Symbol Entity Common Stock, Shares Outstanding Document Type Amendment Flag Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Line of Credit Facility, Interest Rate During Period Line Of Credit Facility Without Prepayment Penalty And Outstanding Without prepayment penalty and the full outstanding was subsequently repaid under the credit facility. Broadfin Healthcare Master Fund Ltd [Member] Document Information [Line Items] Assets, Total Total assets Liabilities and Equity, Total Total liabilities and shareholders' equity